Abortion pills could be BANNED across the US trends now
Mifepristone, unlike its counterpart misoprostol, is only approved for abortion healthcare, as well as, for some miscarriages. It was approved in 2000. Roughly one-half of abortions are completed using the two-pill system
Access to abortion pills is on the line today as a Trump-appointed judge in Texas considers whether to revoke their approval.
Judge Matthew Kacsmaryk of the US District Court for the Northern District of Texas will consider reversing the Food and Drug Administration's approval of the drug mifepristone, marketed as Mifeprex, which would halt the use of the drug nationwide.
He is expected to rule in favor of the anti-abortion group Alliance Defending Freedom that brought the case.
The ruling would have far-reaching implications for American women, even in states where abortion remains legal.
A move to revoke FDA approval would almost certainly be appealed immediately by abortion rights activists, though the appeals court at the fifth circuit that would weigh the case is also very politically conservative.
Medication-induced abortions make up the majority share of abortions carried out today due to the Supreme Court’s 2021 decision in Dobbs v. Jackson that revoked a federal guarantee to the procedure.
The future of abortion access in the US hinges on the thinking of Judge Matthew Kacsmaryk of the United States District Court for the Northern District of Texas, who scheduled the hearing for Wednesday after trying to evade the press.
The case in question is the Alliance for Hippocratic Medicine vs the US FDA, first filed late last year to challenge the FDA’s approval of Mifeprex in 2000, which was a result of stringent rounds of safety and efficacy tests and 12 years of proven safe use abroad in France.
The conservative anti-abortion group Alliance Defending Freedom, which filed the suit for the plaintiffs, is expected to fare well in Judge Kacsmaryk’s court.
Kacsmaryk was appointed to the bench by former President Donald Trump in 2019 and has a judicial track record that aligns with conservative Christian ideology.
The ADF, on the part of the Alliance for Hippocratic Medicine and anti-abortion healthcare providers, argue that: ‘The FDA failed America’s women and girls when it chose politics over science and approved chemical abortion drugs for use in the United States.
‘To date, the FDA’s review, approval, and deregulation of chemical abortion drugs has spanned three decades, correlated with four U.S. presidential elections, and encompassed six discrete agency actions. Plaintiffs challenge these six FDA actions and ask that the Court hold them unlawful, set them aside,
